MedTrace Logo

Clinical Trials

NCT02839707 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
444 participants

Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2017-06-23
Completion:
2023-05-09
Conditions
  • Fallopian Tube High Grade Serous Adenocarcinoma
  • Ovarian High Grade Serous Adenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Primary Peritoneal High Grade Serous Adenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Fallopian Tube Clear Cell Adenocarcinoma
  • Recurrent Fallopian Tube Endometrioid Adenocarcinoma
  • Recurrent Fallopian Tube Undifferentiated Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Endometrioid Adenocarcinoma
  • Recurrent Ovarian Undifferentiated Carcinoma
  • Recurrent Platinum-Resistant Fallopian Tube Carcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Recurrent Platinum-Resistant Primary Peritoneal Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Recurrent Primary Peritoneal Clear Cell Adenocarcinoma
  • Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
  • Recurrent Primary Peritoneal Undifferentiated Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
Results Available
NCT02698293 | WITHDRAWN | PHASE1
0 participants

PDT Plus Vitamin D3 for Anal Dysplasia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2019-12-01
Completion:
2022-08-03
Conditions
  • Anal Dysplasia
  • Carcinoma in Situ
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02610465 | COMPLETED
148 participants

High Image Matrix CT Reconstruction

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-04
Start Date:
2015-11-09
Completion:
2020-03-27
Conditions
  • Healthy Subjects
  • Pulmonary-Related Conditions
  • Cardiac-Related Conditions
No Results Yet
NCT02595944 | ACTIVE_NOT_RECRUITING | PHASE3
903 participants

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2016-07-22
Completion:
2026-12-31
Conditions
  • Stage IB Lung Non-Small Cell Carcinoma AJCC v7
  • Stage II Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT02465060 | ACTIVE_NOT_RECRUITING | PHASE2
6452 participants

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2015-08-17
Completion:
2026-12-31
Conditions
  • Advanced Lymphoma
  • Advanced Malignant Solid Neoplasm
  • Bladder Carcinoma
  • Breast Carcinoma
  • Cervical Carcinoma
  • Colon Carcinoma
  • Colorectal Carcinoma
  • Endometrial Carcinoma
  • Esophageal Carcinoma
  • Exocrine Pancreas Carcinoma
  • Gastric Carcinoma
  • Glioma
  • Head and Neck Carcinoma
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Kidney Carcinoma
  • Liver Carcinoma
  • Lung Carcinoma
  • Lymphoma
  • Malignant Uterine Corpus Neoplasm
  • Malignant Uterine Neoplasm
  • Melanoma
  • Multiple Myeloma
  • Ovarian Carcinoma
  • Prostate Carcinoma
  • Rectal Carcinoma
  • Recurrent Bladder Carcinoma
  • Recurrent Breast Carcinoma
  • Recurrent Cervical Carcinoma
  • Recurrent Colon Carcinoma
  • Recurrent Colorectal Carcinoma
  • Recurrent Esophageal Carcinoma
  • Recurrent Gastric Carcinoma
  • Recurrent Glioma
  • Recurrent Head and Neck Carcinoma
  • Recurrent Liver Carcinoma
  • Recurrent Lung Carcinoma
  • Recurrent Lymphoma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Malignant Uterine Corpus Neoplasm
  • Recurrent Melanoma
  • Recurrent Multiple Myeloma
  • Recurrent Ovarian Carcinoma
  • Recurrent Pancreatic Carcinoma
  • Recurrent Prostate Carcinoma
  • Recurrent Rectal Carcinoma
  • Recurrent Skin Carcinoma
  • Recurrent Thyroid Gland Carcinoma
  • Refractory Lymphoma
  • Refractory Malignant Solid Neoplasm
  • Refractory Multiple Myeloma
  • Skin Carcinoma
  • Thyroid Gland Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT02257528 | ACTIVE_NOT_RECRUITING | PHASE2
26 participants

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2015-05-18
Completion:
2019-03-05
Conditions
  • Cervical Adenocarcinoma
  • Cervical Adenosquamous Carcinoma
  • Recurrent Cervical Carcinoma
  • Stage IV Cervical Cancer AJCC v6 and v7
  • Stage IVA Cervical Cancer AJCC v6 and v7
  • Stage IVB Cervical Cancer AJCC v6 and v7
Interventions
  • OTHER
  • BIOLOGICAL
Results Available
NCT02224781 | ACTIVE_NOT_RECRUITING | PHASE3
267 participants

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2015-09-08
Completion:
2023-09-30
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Recurrent Melanoma
  • Unresectable Melanoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
Results Available
NCT02143414 | ACTIVE_NOT_RECRUITING | PHASE2
53 participants

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2015-06-30
Completion:
2022-06-01
Conditions
  • Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Recurrent Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
Results Available
NCT02115282 | ACTIVE_NOT_RECRUITING | PHASE3
608 participants

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2014-03-29
Completion:
2020-05-05
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Breast Adenocarcinoma
  • HER2/Neu Negative
  • Locally Advanced Breast Carcinoma
  • Metastatic Breast Carcinoma
  • Recurrent Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
Results Available
NCT02101788 | COMPLETED | PHASE2/PHASE3
260 participants

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2014-04-11
Completion:
2019-04-04
Conditions
  • Borderline Ovarian Serous Tumor
  • Micropapillary Serous Carcinoma
  • Ovarian Serous Adenocarcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Recurrent Ovarian Low Grade Serous Adenocarcinoma
  • Recurrent Primary Peritoneal Serous Adenocarcinoma
Interventions
  • DRUG
  • OTHER
Results Available
NCT01524549 | COMPLETED
178 participants

Blood Vessel Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-04
Start Date:
2012-03-01
Conditions
  • Cardiovascular Disease
No Results Yet
NCT01386385 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
53 participants

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2011-06-20
Completion:
2019-05-26
Conditions
  • Lung Adenocarcinoma
  • Lung Adenocarcinoma, Mixed Subtype
  • Lung Large Cell Carcinoma
  • Lung Squamous Cell Carcinoma
  • Minimally Invasive Lung Adenocarcinoma
  • Stage III Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Interventions
  • RADIATION
  • DRUG
  • OTHER
Results Available
NCT01274338 | ACTIVE_NOT_RECRUITING | PHASE3
1673 participants

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2011-06-17
Completion:
2019-02-15
Conditions
  • Melanoma of Unknown Primary
  • Recurrent Melanoma
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
  • BIOLOGICAL
  • OTHER
Results Available
NCT01272037 | ACTIVE_NOT_RECRUITING | PHASE3
5018 participants

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2011-02-28
Completion:
2023-02-01
Conditions
  • Breast Ductal Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Multicentric Breast Carcinoma
  • Multifocal Breast Carcinoma
  • Synchronous Bilateral Breast Carcinoma
Interventions
  • DRUG
  • OTHER
Results Available
Previous
Sorted by latest updates
Next
Showing 40 trials per page